Topics:

Psychopharmacology

Psychopharmacology

Does Ketamine Hold Promise in Mitigating Suicide Risk?

The authors review mechanisms of suicide and the effectiveness of current treatments, and zero in on ketamine--a potential novel, rapidly acting treatment for suicidality.

What psychiatry needs is a new approach to “psychiatric theory.” Here are a few practical suggestions.

A 28-year-old married mother of 2 with a history of depression is brought to the emergency department after 6 months of near-daily methamphetamine use.

Update on Psychogenic Nonepileptic Seizures

The authors take an in-depth look at the evaluation, diagnosis, and fundamental treatment recommendations, protocols, and guides to therapy for psychogenic nonepileptic seizures.

The potential of TMS as a treatment for cognitive disorders, fatigue, pain, and other manifestations of brain disease is discussed, as is the encouraging prospect for neuropsychiatric management of many patients.

Phenomenology in an Acute Care Setting

We present the case of a patient for whom different attending providers had markedly different interpretations. As the case unfolds, we invite you to reflect on your diagnostic understanding of each presentation.

In this podcast, two psychiatrists discuss current clinical research and the future of treatment options for obsessive-compulsive disorder.

Pages

Subscribe to Psychopharmacology on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.